Background. Effectiveness of human papillomavirus (HPV) vaccines in the context of both guidelines, which recommend vaccination at 14 years and modest vaccine coverage, is poorly documented.Heard, IsabelleTondeur, LauraArowas, LaurenceDemazoin, MarieFalguieres, MichaelDu Chatelet, Isabelle Parent...
Human papillomavirus (HPV) infection has been shown to be a major risk factor for cervical cancer. Vaccines against HPV-16 and HPV-18 are highly effective in preventing type-specific HPV infections and related cervical lesions. There is, however, limited
Human papillomavirus (HPV) infection has been shown to be a major risk factor for cervical cancer. Vaccines against HPV-16 and HPV-18 are highly effective in preventing type-specific HPV infections and related cervical lesions. There is, however, limited
Human papillomavirus (HPV) infection has been shown to be a major risk factor for cervical cancer. Vaccines against HPV-16 and HPV-18 are highly effective in preventing type-specific HPV infections and related cervical lesions. There is, however, limited
The recent approval of human papillomavirus (HPV) vaccine means that decision makers need information beyond that available from randomized clinical trials to recommend funding for this vaccination programme. Modelling and economic studies have addressed some of those information needs. We conducted a qual...
Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United StatesCost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United StatesBackground: Women older than 30 years...
In this study, apart from the matching variables (age group and workplace), characteristics including gender, duration of vaccination, comorbidities, smoking and education levels were also collected, and severed as covariates. These characteristics of test-positive (cases) and test-negative HUMAN ...
The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model. Based on a mathematical model simulating the transmission dynamics and the natural history ...
Objective: To assess the cost-utility of the human papillomavirus (HPV) vaccination on the prevention of cervical cancer in the Brazilian Amazon region.Methods: A Markov cohort model was developed to simulate the natural evolution of HPV and its progress to cervical cancer, considering the current...
Background: The aim of the study was to estimate the cost-effectiveness of addition of human papillomavirus (HPV) vaccination to the Polish cervical cancer prevention programme. Methods: A cost-utility analysis was conducted. A lifetime Markov model, adapted to Polish settings, was used to compar...